Mathilde Lamarque

The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience

Mathilde Lamarque, Sophie Raynaud, Raphaël Itzykson et al. · Blood · 2012 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +2

Significance of Measurable Residual Disease in Adult Philadelphia Chromosome–Positive ALL: A GRAAPH-2014 Study

Rathana Kim, Yves Chalandon, Philippe Rousselot et al. · Journal of Clinical Oncology · 2024 · 39 citations · Full text

Medicine, Hematology, Oncology +16

XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia

Flavia Guillem, Michaël Dussiot, Elia Colin et al. · Haematologica · 2019 · 36 citations · Full text

Life Sciences, Hematology, Molecular Biology +15

Enhanced Renewal of Erythroid Progenitors in Myelodysplastic Anemia by Peripheral Serotonin

David Sibon, Téreza Coman, Julien Rossignol et al. · Cell Reports · 2019 · 22 citations · Full text

Medicine, Hematology, Pharmacology +16

Protein-based therapeutic for anemia caused by dyserythropoiesis

Jean‐Benoît Arlet, Flavia Guillem, Mathilde Lamarque et al. · Expert Review of Proteomics · 2016 · 11 citations

Life Sciences, Hematology, Molecular Biology +13